 |
Kekst CNC represents Avista Capital Partners as the private equity firm acquires the dermatology and topicals business of G&W Laboratories.
The addition of G&W Dermatology to ACP’s investment portfolio is part of its strategy to “identify attractive niche healthcare assets and then acquire such businesses via a carve-out transaction,” according to Sriram Venkataraman, Avista partner.
Avista has named Walt Kaczmarek, a 25-year veteran of the pharmaceuticals sector, CEO of G&W Dermatology.
Carl Greenblatt, a pharmacist who served with the US Army during WWI, founded G&W Laboratories in 1919 His son, Burton, also a pharmacist, joined the company after he returned from service during WWII. A fourth-generation Greenblatt, Aaron, currently helms the company.
Kekst CNC’s Daniel Yunger, Sherri Toub and Daniel Hoadley represent Avista, which has more than $6B invested in 30 health-oriented businesses.
Publicis Groupe owns Kekst CNC.
Edelman handles Viking Holdings, the river and ocean luxury cruise line that plans to raise $1B via an IPO priced in the $21 to $25 per share range.
Teneo is handling the initial public offering of CVC Capital Partners, one of Europe’s largest private equity firms with nearly $200B in assets under management.
Brunswick Group represents Endeavor Group Holdings as it agrees to go private via its acquisition by Silver Lake technology investment firm, which is handled by Edelman Smithfield.
Tod Donhauser, a nine-year veteran of Edelman, has joined H/Advisors Abernathy as managing director and head of its San Francisco office.
Intelligent Group Ltd, a Hong Kong-based financial PR firm, has priced its initial public offering of 1.9M shares at $4, which is the low end of the $4 to $5 range.
Have a comment? Send it to 
No comments have been submitted for this story yet.